VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, announced that it has raised $140 million in private financing, that includes $25 million in the second tranche…
According to filings with the U.S. Securities and Exchange Commission, SetPoint Medical is raising up to $114,999,987.54 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
According to filings with the U.S. Securities and Exchange Commission, SetPoint Medical is raising $80,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Murthy Simhambhatla played a key…
Valencia, CA – According to filings with the U.S. Securities and Exchange Commission, SetPoint Medical is raising $64,407,963.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Murthy Simhambhatla…
Valencia, CA – According to filings with the U.S. Securities and Exchange Commission, SetPoint Medical is raising $20,500,000.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive…